{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:24:31Z","timestamp":1778858671079,"version":"3.51.4"},"reference-count":43,"publisher":"SLACK, Inc.","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychosoc Nurs Ment Health Serv"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>\n            Alcohol use disorder (AUD) is a serious, prevalent disorder that affects millions of people. There are numerous evidence-based treatments and strategies to treat AUD, but they are under-utilized for a variety of reasons, including provider stigma, lack of knowledge, lack of professional support, shortage of willing providers, and patient barriers. Disulfiram, naltrexone, and acamprosate are approved but underused medications for the treatment of AUD. Nonpharmacological strategies and treatments include the use of motivational interviewing when talking to patients about their alcohol use, peer support or mutual help groups, and individualized therapy. Nurses are in a prime position to educate themselves and patients on evidence-based treatments for AUD and to help patients access those treatments. [\n            <jats:italic>Journal of Psychosocial Nursing and Mental Health Services, 59<\/jats:italic>\n            (12), 7\u201311.]\n          <\/jats:p>","DOI":"10.3928\/02793695-20211110-01","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T14:26:23Z","timestamp":1638282383000},"page":"7-11","source":"Crossref","is-referenced-by-count":3,"title":["Review of Evidence-Based Strategies to Treat Alcohol Use Disorder"],"prefix":"10.3928","volume":"59","author":[{"given":"Julie","family":"Worley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.19r02465"},{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0249"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1037\/adb0000237"},{"key":"e_1_3_1_5_1","author":"Beck Institute","year":"2019","unstructured":"Beck Institute. (2019). Treating substance misuse disorders with CBT. https:\/\/beckinstitute.org\/treating-substance-misuse-disorders-cbt\/","journal-title":"Treating substance misuse disorders with CBT"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agy089"},{"key":"e_1_3_1_7_1","author":"EMDR Institute","year":"2019","unstructured":"EMDR Institute. (2019). Frequent questions. https:\/\/www.emdr.com\/frequent-questions\/","journal-title":"Frequent questions"},{"key":"e_1_3_1_8_1","author":"Epocrates","year":"2021","unstructured":"Epocrates. (2021). Naltrexone. https:\/\/online.epocrates.com\/drugs\/5310\/naltrexone\/Monograph","journal-title":"Naltrexone"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/1556035X.2012.705662"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2017.03.005"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204890"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000338"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1037\/a0022487"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.54.5.621"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.2001.62.528"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12070"},{"key":"e_1_3_1_18_1","first-page":"CD012880","article-title":"Alcoholics Anonymous and other 12-step programs for alcohol use disorder.","volume":"3","author":"Kelly J. F.","year":"2020","unstructured":"Kelly, J. F., Humphreys, K., & Ferri, M. (2020). Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database of Systematic Reviews, 3, CD012880. PMID:32159228","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_3_1_19_1","author":"LifeRing\u00ae Secular Recovery","year":"2020","unstructured":"LifeRing\u00ae Secular Recovery. (2020). About LifeRing. https:\/\/lifering.org\/lifering-recovery-menu","journal-title":"About LifeRing"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14224"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1037\/ccp0000447"},{"key":"e_1_3_1_22_1","unstructured":"Maranda S. & Abdijadid S. (2021). Disulfiram. In StatPearls [Internet] . https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459340\/"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1891\/1933-3196.13.3.187"},{"key":"e_1_3_1_24_1","author":"Moderation Management\u2122","year":"2020","unstructured":"Moderation Management\u2122. (2020). Behaviors can be changed. https:\/\/moderation.org\/about-mm-support-overview\/our-purpose\/","journal-title":"Behaviors can be changed"},{"key":"e_1_3_1_25_1","author":"National Institute on Alcohol Abuse and Alcoholism","year":"2021","unstructured":"National Institute on Alcohol Abuse and Alcoholism. (2021). Alcohol use in the United States. https:\/\/www.niaaa.nih.gov\/publications\/brochures-and-fact-sheets\/alcohol-facts-and-statistics","journal-title":"Alcohol use in the United States"},{"key":"e_1_3_1_26_1","author":"National Institute on Drug Abuse","year":"2016","unstructured":"National Institute on Drug Abuse. (2016, May 26). FDA approves six month implant for treatment of opioid dependence. https:\/\/archives.drugabuse.gov\/news-events\/news-releases\/2016\/05\/fda-approves-six-month-implant-treatment-opioid-dependence","journal-title":"FDA approves six month implant for treatment of opioid dependence"},{"key":"e_1_3_1_27_1","author":"National Institute on Drug Abuse","year":"2020","unstructured":"National Institute on Drug Abuse. (2020). Drugs, brains, and behavior: The science of addiction. Can addiction be treated successfully? https:\/\/www.drugabuse.gov\/publications\/drugs-brains-behavior-science-addiction\/treatment-recovery","journal-title":"Drugs, brains, and behavior: The science of addiction. Can addiction be treated successfully?"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.22942"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S145201"},{"key":"e_1_3_1_30_1","author":"R\u00f6sner S.","year":"2010","unstructured":"R\u00f6sner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., & Soyka, M. (2010). Acamprosate for alcohol dependent patients. https:\/\/www.cochrane.org\/CD004332\/ADDICTN_acamprosate-for-alcohol-dependent-patients","journal-title":"Acamprosate for alcohol dependent patients"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/07347324.2019.1584019"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.112645"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.20170039"},{"key":"e_1_3_1_34_1","unstructured":"Singh D. & Saadabadi A. (2021). Naltrexone. In StatPearls [Internet] . https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534811\/"},{"key":"e_1_3_1_35_1","author":"SMARTRecovery\u00ae","year":"2021","unstructured":"SMARTRecovery\u00ae.(2021). About SMART Recovery. https:\/\/www.smartrecovery.org\/about-us\/","journal-title":"About SMART Recovery"},{"key":"e_1_3_1_36_1","author":"Substance Abuse and Mental Health Services Administration","year":"2009","unstructured":"Substance Abuse and Mental Health Services Administration. (2009). Treatment improvement protocols. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK64035\/","journal-title":"Treatment improvement protocols"},{"key":"e_1_3_1_37_1","author":"Substance Abuse and Mental Health Services Administration","year":"2015","unstructured":"Substance Abuse and Mental Health Services Administration. (2015). Clinical use of extended-release injectable naltrexone in the treatment of opioid use disorder: A brief guide. https:\/\/store.samhsa.gov\/sites\/default\/files\/d7\/priv\/sma14-4892r.pdf","journal-title":"Clinical use of extended-release injectable naltrexone in the treatment of opioid use disorder: A brief guide"},{"key":"e_1_3_1_38_1","author":"Troncale J","year":"2017","unstructured":"Troncale, J. (2017, December 20). Acceptance\u2013commitment therapy (ACT) in addiction treatment and relapse prevention. https:\/\/www.naadac.org\/assets\/2416\/2017_12_19-using_act_in_addiction_treatment_webinarslides.pdf","journal-title":"Acceptance\u2013commitment therapy (ACT) in addiction treatment and relapse prevention"},{"key":"e_1_3_1_39_1","author":"U.S. Department of Health and Human Services","year":"2019","unstructured":"U.S. Department of Health and Human Services. (2019). Best practices and barriers to engaging people with substance use disorders in treatment. https:\/\/aspe.hhs.gov\/reports\/best-practices-barriers-engaging-people-substance-use-disorders-treatment","journal-title":"Best practices and barriers to engaging people with substance use disorders in treatment"},{"key":"e_1_3_1_40_1","author":"White W. L.","year":"2012","unstructured":"White, W. L. (2012). Recovery\/remission from substance use disorders. https:\/\/www.naadac.org\/assets\/2416\/whitewl2012_recoveryremission_from_substance_abuse_disorders.pdf","journal-title":"Recovery\/remission from substance use disorders"},{"key":"e_1_3_1_41_1","author":"Women for Sobriety","year":"2021","unstructured":"Women for Sobriety. (2021). Vision, mission, values. https:\/\/womenforsobriety.org\/about\/","journal-title":"Vision, mission, values"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20190815-02"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20200115-02"},{"key":"e_1_3_1_44_1","unstructured":"Yasaei R. Katta S. & Saadabadi A. (2021). Gabapentin. In StatPearls [Internet] . https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493228"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.02.004"}],"container-title":["Journal of Psychosocial Nursing and Mental Health Services"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T06:34:32Z","timestamp":1683095672000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/02793695-20211110-01"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.3928\/02793695-20211110-01"],"URL":"https:\/\/doi.org\/10.3928\/02793695-20211110-01","relation":{},"ISSN":["0279-3695","1938-2413"],"issn-type":[{"value":"0279-3695","type":"print"},{"value":"1938-2413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]}}}